B0AT1 could become a therapeutic target for drug screening to eliminate SARS-CoV-2 infection.
B0AT1 inaweza kuwa kilengwa ya kimatibabu kwa ajili ya uchunguzi wa dawa ya kudidimiza maambukizi ya SARS-CoV-2.